| Authors: |
Duncker PC; Holtom-Garrett Program in Neuroimmunology, Department of Neurology, University of Michigan School of Medicine, Ann Arbor, MI 48109.; Multiple Sclerosis Center, Department of Neurology, University of Michigan School of Medicine, Ann Arbor, MI 48109.; Graduate Program in Immunology, University of Michigan School of Medicine, Ann Arbor, MI 48109; and., Stoolman JS; Holtom-Garrett Program in Neuroimmunology, Department of Neurology, University of Michigan School of Medicine, Ann Arbor, MI 48109.; Multiple Sclerosis Center, Department of Neurology, University of Michigan School of Medicine, Ann Arbor, MI 48109.; Graduate Program in Immunology, University of Michigan School of Medicine, Ann Arbor, MI 48109; and., Huber AK; Holtom-Garrett Program in Neuroimmunology, Department of Neurology, University of Michigan School of Medicine, Ann Arbor, MI 48109.; Multiple Sclerosis Center, Department of Neurology, University of Michigan School of Medicine, Ann Arbor, MI 48109., Segal BM; Holtom-Garrett Program in Neuroimmunology, Department of Neurology, University of Michigan School of Medicine, Ann Arbor, MI 48109; bmsegal@med.umich.edu.; Multiple Sclerosis Center, Department of Neurology, University of Michigan School of Medicine, Ann Arbor, MI 48109.; Graduate Program in Immunology, University of Michigan School of Medicine, Ann Arbor, MI 48109; and.; Neuroscience Program, University of Michigan School of Medicine, Ann Arbor, MI 48109. |